| [1] |
敬丽桦, 张宇, 王笑影, 等.结直肠癌肝转移患者的临床特征及与预后的关系[J].实用医院临床杂志, 2022, 19(1): 135-138.
|
| [2] |
李书琪, 朱绍成.钆塞酸二钠增强MRI 在结直肠癌肝转移瘤精准诊断与治疗评估中的临床应用及前沿进展[J].影像科学与光化学, 2025, 43(1): 3-9, 16.
|
| [3] |
张怡清.结直肠癌肝转移患者的临床特征及其预后分析[D].长春: 吉林大学, 2022.
|
| [4] |
张馨雅, 王一凡, 李金铭, 等.结直肠癌肝转移患者新辅助化疗效果相关的肠道菌群和代谢物特征及其临床预测价值[J].中华检验医学杂志, 2024, 47(7): 779-788.
|
| [5] |
王旭.结直肠癌肝转移患者基因突变特点及其与临床病理特征和预后的关系[D].长春: 吉林大学, 2023.
|
| [6] |
Han Y, Zeng S, Feng Z, et al.Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma[J].Comput Biol Med, 2023, 158: 106862.
|
| [7] |
Zhang Z, Zhang X.Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer[J].Med Sci Monit,2021, 27: e932370.
|
| [8] |
王韡, 程晋坤, 杨政道.伊立替康联合卡培他滨和贝伐珠单抗治疗结直肠癌伴肝转移患者的临床研究[J].中国临床药理学杂志,2024, 40(18): 2660-2664.
|
| [9] |
汪涛, 胡可俊, 鲁斌.腹腔镜下直肠癌根治术加肝部分切除术在结直肠癌伴肝转移中的临床应用[J].中国现代普通外科进展,2023, 26(5): 385-388.
|
| [10] |
马钊, 杨越, 曹景玉, 等.中性粒细胞淋巴细胞比值与两医院7 187例结直肠癌肝转移临床资料回顾分析[J].中华肿瘤防治杂志, 2020,27(12): 992-997.
|
| [11] |
刘琦.RAB7A 在胰腺癌中的表达及其临床意义[D].郑州: 郑州大学, 2023.
|
| [12] |
Xie Y, Zhou Y, Wang J, et al.Ferroptosis, autophagy, tumor and immunity[J].Heliyon, 2023, 9(9): e19799.
|
| [13] |
Zhou B, Liu J, Kang R, et al.Ferroptosis is a type of autophagy-dependent cell death[J].Semin Cancer Biol, 2020, 66:89-100.
|
| [14] |
张敏, 刘生宝, 张诺, 等.高表达RAB7A 通过促进肿瘤侵袭影响胃癌患者的预后[J].南方医科大学学报, 2023, 43(10): 1734-1743.
|
| [15] |
徐凤英, 刘儒, 马丽, 等.乳腺癌MDA-MB-231 细胞中Rab7a 基因的网络分析[J].吉林大学学报(医学版), 2020, 46(3): 464-469,后插3.
|
| [16] |
张彤, 周妍, 吴巍.生物信息学分析萝卜硫素上调RAB7 交互溶酶体蛋白与非小细胞肺癌细胞自噬的关联[J].山西医科大学学报, 2022, 53(4): 383-389.
|
| [17] |
Shan Z, Chen X, Chen H, et al.Investigating the impact of Ras-related protein RAB7A on colon adenocarcinoma behavior and its clinical significance[J].Biofactors, 2025, 51(1): e70006.
|
| [18] |
杨立胜, 刘梦鸾, 任维聃, 等.基于血清肿瘤标志物预测结直肠癌肝转移模型价值分析[J/OL].中华普通外科学文献(电子版),2024, 18(1): 39-43.
|
| [19] |
Xie J, Yan Y, Liu F, et al.Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells[J].Biosci Rep, 2019, 39(2): BSR20180480.
|
| [20] |
Shen C, Liu J, Liu H, et al.Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells[J].Phytomedicine, 2024, 122: 155079.
|
| [21] |
Yu W, Ke X, Li M, et al.Downregulation of RAB7 and Caveolin-1 increases MMP-2 activity in renal tubular epithelial cells under hypoxic conditions[J].Open Med(Wars), 2021, 16(1): 1428-1437.
|
| [22] |
Zhang Z, Zhang X.Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer[J].Med Sci Monit,2021, 27: e932370.
|
| [23] |
Kobylarz MJ, Goodwin JM, Kang ZB, et al.An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cells[J].PLoS One, 2020, 5(8): e0235551.
|
| [24] |
Zaidi MR, Soboloff J.TPC2 controls MITF expression and metastasis in melanoma[J].Cell Calcium, 2025, 125: 102989.
|
| [25] |
Heo JM, Ordureau A, Swarup S, et al.RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway[J].Sci Adv, 2018, 4(11): eaav0443.
|
| [26] |
宋佳茹, 朱席琳, 伍晓盼, 等.巯基化Ras 相关蛋白7a 抑制人肝癌细胞系HepG2.2.15 中HBV 复制[J].基础医学与临床, 2020,40(1): 37-40.
|
| [27] |
Xie J, Yan Y, Liu F, et al.Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells[J].Biosci Rep, 2019, 39(2): BSR20180480.
|
| [28] |
Margiotta A, Progida C, Bakke O, et al.Rab7a regulates cell migration through Rac1 and vimentin[J].Biochim Biophys Acta Mol Cell Res, 2017, 1864(2): 367-381.
|
| [29] |
Sun Q, Long L.Diagnostic performances of methylated septin9 gene,CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer[J].BMC Cancer, 2024, 24(1): 906.
|